// App-Quantinova.ai

4079 : Are Outcomes Worse For Patients With Polycythemia Vera compared to Polycythemia Of Unknown Cause? a Retrospective Analysis Of Single Institution Patient Cohorts

Researchers

Presenter

  • Joseph Chacko

Principal Investigators

  • Sara Boyce

  • Sally Killick

  • Hall Rachel

  • Helen McCarthy

  • Walewska Renata

  • Louise Wallis

Medical Centers

  • Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Acute myelocytic leukemia

  • Polycythemia vera

  • Venous thrombosis

  • Alcohol Dependence

  • Myelofibrosis

  • Renal disease

  • Sleep apnoea

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxycarbamide

  • Erythropoietin

  • Interferon

  • Busulfan

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved